Research & Development

Give To Cure Launches Crowdfunding Nonprofit to…

Innovative new organization uses crowdfunding to fund clinical trials bringing cures to market faster.

Blockade Medical’ Announces Closing of Equity Financing…

Blockade Medical LLC, a privately held company focused on the development of catheter based therapeutic devices for the treatment of…

Third Quarter Results Show NHS in Need…

Quarterly Results published by Monitor and the NHS Trust Development Agency show serious financial pressures on NHS Foundation Trusts

SurModics Receives FDA IDE Approval for Early…

The development of the SurVeil DCB is a major step forward.

Swiss Researchers Explore Benefits of Mediterranean Diet

First study of its kind in Switzerland explores lifestyle choices and how these impact on health

Lipid Therapeutics Licenses Rights to its Novel…

Lipid Therapeutics today announced that it has entered into a licensing agreement with Nestl' Health Science

Apaziquone set for Phase Three Trial

Spectrum Pharmaceuticals announces agreement with FDA on the Special Protocol Assessment (SPA)

Accelerated Assessment for Ixazomib

European Medicines Agency Grants Accelerated Assessment of Ixazomib for Patients with Relapsed/Refractory Multiple Myeloma

Evidence Shows New Technique Spares More Breast…

A new study published in the journal Plastic and Reconstructive Surgery proves that more breast cancer patients can qualify for…